Systematic Review of Intravenous Ascorbate in Cancer Clinical Trials
Background: Ascorbate (vitamin C) has been evaluated as a potential treatment for cancer as an independent agent and in combination with standard chemotherapies. This review assesses the evidence for safety and clinical effectiveness of intravenous (IV) ascorbate in treating various types of cancer....
Saved in:
Main Authors: | Gina Nauman (Author), Javaughn Corey Gray (Author), Rose Parkinson (Author), Mark Levine (Author), Channing J. Paller (Author) |
---|---|
Format: | Book |
Published: |
MDPI AG,
2018-07-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
The effect of intravenous ascorbic acid in hemodialysis patients with normoferritinemic anemia
by: Dae Woong Kang, et al.
Published: (2012) -
Cabazitaxel: a novel second-line treatment for metastatic castration-resistant prostate cancer
by: Channing J Paller, et al.
Published: (2011) -
Corrigendum
by: Channing J Paller, et al.
Published: (2011) -
Review of the Potential Role of Ascorbate in the Prevention and Treatment of Gynecological Cancers
by: Xiaochang Shen, et al.
Published: (2024) -
EFFECTIVENESS OF ASCORBIC ACID AND SALINE SOLUTION IN PEDIATRIC CENTRAL VENOUS ACCESS: RANDOMIZED CLINICAL TRIAL
by: Letícia Morgana Giacomozzi, et al.
Published: (2022)